A number of methodologies are being developed that you need to watch.!--h2>
Enal Razvi, Ph.D.
The focus of this GEN Market & Tech Analysis report is our continuing coverage of the mass spectrometry space as it's translating from research to clinic, the third report in a series focused on mass spectrometry and its clinical deployment that also includes "Mass Spec Market Snapshot" and "Laboratory-Developed Tests Based on Mass Spec". Highlights:
Overall theme: trends in sample preparation and multiplexing in mass spectrometry.
As mass spectrometry translates from research to clinic, a number of methodologies for front-end sample preparation are being developed. This report provides a snapshot of these efforts.
Multiplexed mass spectrometry as a means to detect multiple analytes simultaneously is a space which we continue to characterize—presented here are some methodologies that are being developed with an emphasis towards clinical utilization (for example, for the detection of pathogens).
These efforts en bloc suggest a definite translation of this discipline toward the clinic.
Enal Razvi, Ph.D., conducted his doctoral work on viral immunology and subsequent to receiving his Ph.D. went on to the Rockefeller University in New York to serve as Aaron Diamond Post-doctoral fellow under Professor Ralph Steinman [Nobel Prize Winner in 2011 for his discovery of dendritic cells in the early-70s with Zanvil Cohn]. Subsequently, Dr. Razvi completed his research fellowship at Harvard Medical School. For the last two decades Dr. Razvi has worked with small and large companies and consulted for more than 100 clients worldwide. He currently serves as Biotechnology Analyst and Managing Director of SelectBio U.S. He can be reached at firstname.lastname@example.org.